about
Interaction with calmodulin is important for the secretion of thimet oligopeptidase following stimulationAptamer for imaging and therapeutic targeting of brain tumor glioblastomaHuman adult stem cells from diverse origins: an overview from multiparametric immunophenotyping to clinical applicationsEcto-5'-Nucleotidase Overexpression Reduces Tumor Growth in a Xenograph Medulloblastoma ModelModulation of mouse embryonic stem cell proliferation and neural differentiation by the P2X7 receptorExtrinsic purinergic regulation of neural stem/progenitor cells: implications for CNS development and repairNatural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulinInhibition mechanism of the recombinant rat P2X(2) receptor in glial cells by suramin and TNP-ATPMechanism-based discovery of ligands that counteract inhibition of the nicotinic acetylcholine receptor by cocaine and MK-801.RNA and DNA aptamers in cytomics analysis.Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta.DNA and RNA aptamers as modulators of protein function.DNA and RNA aptamers: from tools for basic research towards therapeutic applications.Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.Disease-specific biomarker discovery by aptamers.Development of the anti-VEGF aptamer to a therapeutic agent for clinical ophthalmology.Aptamers: from bench side research towards patented molecules with therapeutic applications.RNA based antagonist of NMDA receptorsKinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonistsCharacterization of ectonucleotidases in human medulloblastoma cell lines: ecto-5'NT/CD73 in metastasis as potential prognostic factor.Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Rescue of amyloid-Beta-induced inhibition of nicotinic acetylcholine receptors by a peptide homologous to the nicotine binding domain of the alpha 7 subtype.Antibody- and aptamer-strategies for GvHD prevention.The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations.Involvement of nucleotides in glial growth following scratch injury in avian retinal cell monolayer cultures.A Cyclic GMP-Dependent K+ Channel in the Blastocladiomycete Fungus Blastocladiella emersonii.Water soluble RNA based antagonist of AMPA receptorsParaoxon and Pyridostigmine Interfere with Neural Stem Cell DifferentiationAmino acid metabolic routes in Trypanosoma cruzi: possible therapeutic targets against Chagas' disease.Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Kinin-B2 receptor activity determines the differentiation fate of neural stem cellsIn vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor.Variations of ATP and its metabolites in the hippocampus of rats subjected to pilocarpine-induced temporal lobe epilepsyIs there a rational approach for increasing drug specificity? Considerations on CNS target choice and validation.New insights into purinergic receptor signaling in neuronal differentiation, neuroprotection, and brain disorders.Novel perspectives of neural stem cell differentiation: from neurotransmitters to therapeutics.Actions of octocoral and tobacco cembranoids on nicotinic receptors.Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents.Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications.Functions of neurotrophins and growth factors in neurogenesis and brain repair.
P50
Q24315786-FA8D850F-3F6A-47DB-84C6-AC2608C6C600Q26799218-EE24EBFD-6391-48C1-A804-3FF8BBA3438FQ26998695-1C08B2DC-B7A6-45D8-917F-3114932C8414Q27312282-33D2979B-1077-430A-BE1E-7193C853B26BQ27334899-E5B992D8-0B3E-4DD8-839F-736D88C5CE83Q28265633-EAAE3D3C-0C44-4EB9-97C9-3845B6A51537Q28573313-305AEC49-3ED3-4F32-ABCF-E0B3680A863AQ28575208-8CC26F2F-9529-4BBC-A0E1-C06746ED58E6Q30970994-6F0C5975-997A-48EC-B3C3-D0C3902540A4Q33203304-D4ABA2DE-3A26-473F-AF9C-ADDC9F14E701Q33218208-C7EA57A3-0213-4220-A915-82210D8B4000Q33247338-1396D473-D616-4CC1-B65B-46FC9004A10FQ33259228-F4789C78-EF04-4792-9AFA-9114802D0BB8Q33283786-E88CBDF6-914B-4373-95FA-764DF4FAB9A3Q33476242-1B78CE26-69F3-4079-AA6F-727351A97B0CQ33492343-A40C9E62-DF14-45ED-BFEF-4707D9551530Q33512089-B3B7FAEC-A744-4D4D-BC84-FDDDF68E6AC9Q33918208-303FA14B-25DE-4C81-AF20-D2722B4150C2Q34163259-E9DCDE65-60E3-4B12-80D8-5ADB7C9ED285Q34456325-5EFEB394-624C-438D-B9B3-EEC13AE2422BQ34674792-A97329B8-3FE1-41D2-9985-89A13D9A2C1EQ34872425-5A76975C-CBA6-49A7-B1F0-DFA679478C9DQ34885269-86C7DE54-1593-40E9-835B-87D1453A2122Q35018850-F1781236-DB52-45D5-961B-014996287851Q35587824-33266B20-957C-45D8-93B1-5BC65BDB00A2Q35684902-73FF55FC-9C60-4C93-984E-09CFC7155EE2Q36026579-C3CF0256-181D-4A85-804E-CBD553B2CC87Q36053144-8A0F2BC3-E3DC-4292-8E8F-58C6FE41E226Q36074405-81002914-6DF0-4B27-881D-FAE02AB948B8Q36310954-86BF8B61-366F-427B-8AB3-B13DAC6D2FE3Q36492736-D55CDE14-FBC2-4325-AB11-76E7DB7A9DF5Q36729048-2DB03DA0-F53B-4816-B037-E4B62312580FQ36863531-FFA0348D-D4CC-4ECC-9C2C-227CB44CD332Q37067434-0824298D-61F5-49BD-9C2B-7DD82175A042Q37135526-548FC7A6-8205-47E7-8358-409C8CD07331Q37318996-BD7B92E9-0ED2-4F3D-86AA-2F99CF828AF9Q37413531-8151ECC4-D595-407B-9A44-A7FAD287EF2EQ37497014-6D10ECF6-8EDD-4146-8C50-CF71DBE512BFQ38048723-567E230C-0314-4339-AA11-28257FEAE697Q38050300-87FFD8FF-22C3-4C64-B0BC-CF2CECA10392
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Henning Ulrich
@ast
Henning Ulrich
@en
Henning Ulrich
@es
Henning Ulrich
@nl
Henning Ulrich
@sl
type
label
Henning Ulrich
@ast
Henning Ulrich
@en
Henning Ulrich
@es
Henning Ulrich
@nl
Henning Ulrich
@sl
prefLabel
Henning Ulrich
@ast
Henning Ulrich
@en
Henning Ulrich
@es
Henning Ulrich
@nl
Henning Ulrich
@sl
P106
P31
P496
0000-0002-2114-3815